Although it has been debated for a long time, several different laboratories using different antibodies do detect myostatin as a 26-kDa protein, which is either a dimer of ϳ12-kDa mature myostatin or in fact the ϳ12-kDa protein tracking slower on SDS-PAGE due to posttranslational modifications (2-6). In McFarlane et al. (7) we see a strong positive myostatin band at 26 kDa, and this specific band is missing in the myostatin-null muscle. However, a faint band tracking slightly above the 26-kDa myostatin band is observed in the myostatin-null muscle tissue, which should not be mistaken for myostatin. As for the Zimmers et al. (8) publication, the size of the nonspecific band is below 26 kDa and as such is not the 26-kDa band that we observe for myostatin.
We disagree that myostatin expression is not detected in liver. In addition to our previous publication (9), other laboratories have detected myostatin expression in liver (10, 11).
The Escherichia coli recombinant myostatin protein is purified under denaturing conditions. Upon renaturing, the protein forms biologically active dimers and inactive multimers; hence high concentrations of the protein are required in our bioassays. It has been difficult to determine the ratio of multimeric to dimeric myostatin due to the high cysteine content of myostatin. Importantly, the E. coli recombinant myostatin protein has been validated and shown to have the same biological function as CHO cell expressed and secreted myostatin (produced by Se-Jin Lee's lab) (12).
Therefore we conclude that both the anti-myostatin antibody and myostatin recombinant protein used in this current study are validated reagents. 
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